Skip to main content

Enrollment in the Health Benefits for Immigrant Adults (HBIA) program will be temporarily paused effective July 1, 2023.

Enrollment in the Health Benefits for Immigrant Seniors (HBIS) program will be temporarily paused effective Nov. 6, 2023.

Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: December 3, 2008

Drug Name Review Type Class Manufacturer
Alvesco New Drug Initial Review Inhaled Steroids Sepracor
Keppra XR New Drug Initial Review Anticonvulsants UCB
Venlafaxine ER New Drug Initial Review Antidepressants � Other Upstate
Pataday New Drug Initial Review Ophthalmics- Allergic Conjunctivitis Alcon
Factive New Drug Appeal Quinolones Oscient
Patanase New Drug Appeal Nasal Preparations � Other Alcon